Concepedia

Publication | Open Access

High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy

53

Citations

26

References

2018

Year

References

YearCitations

Page 1